Még nem toboroz
Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving Surgery
NCT07723469· 3. fázis· SURGE Therapeutics· Forrás
Contact: Melissa Rodgman
Toboroz
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
NCT07621718· 3. fázis· Revolution Medicines, Inc.· Forrás
Contact: Currier
Toboroz
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
NCT07124078· 2. fázis· Incyte Corporation· Forrás
Toboroz
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
NCT07280013· 1. fázis· C4 Therapeutics, Inc.· Forrás
Contact: Study Medical Officer
Toboroz
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07252232· 3. fázis· Revolution Medicines, Inc.· Forrás
Contact: Revolution Medicines Study Director
Toboroz
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
NCT07222800· 3. fázis· Pfizer· Forrás
Toboroz
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
NCT07227012· 1/2. fázis· Pfizer· Forrás
Toboroz
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
NCT07103018· 1. fázis· K36 Therapeutics, Inc.· Forrás
Contact: Hannah McManus, MD (principal investigator)
Toboroz
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
NCT07094113· 1. fázis· Amgen· Forrás
Toboroz
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109· 3. fázis· Nuvalent Inc.· Forrás
Contact: Thomas Stinchcombe, M.D. (principal investigator)
Toboroz
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
NCT06710548· Dana-Farber Cancer Institute· Forrás
Contact: Amelia Scott
Toboroz
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT06690775· 2. fázis· TORL Biotherapeutics, LLC· Forrás
Contact: Principal Investigator
Toboroz
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
NCT05096481· 2. fázis· Nationwide Children's Hospital· Forrás
Contact: Daniel Landi, MD
Toboroz
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
NCT06252649· 3. fázis· Amgen· Forrás
Toboroz
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
NCT06264180· 3. fázis· Replimune, Inc.· Forrás
Contact: Georgia Beasley, MD (principal investigator)
Toboroz
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
NCT06263231· 3. fázis· Intensity Therapeutics, Inc.· Forrás
Contact: Richard Riedel, MD
Toboroz
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
NCT05659381· 3. fázis· GOG Foundation· Forrás
Contact: Karen Grace
Toboroz
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT06161025· 2/3. fázis· Daiichi Sankyo· Forrás
Fut, nem toboroz
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
NCT06111235· 3. fázis· CG Oncology, Inc.· Forrás
Fut, nem toboroz
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
NCT05682443· 1/2. fázis· OncoC4, Inc.· Forrás
Toboroz
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT06120283· 1. fázis· BeOne Medicines· Forrás
Contact: Study Director
Toboroz
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
NCT06040541· 1. fázis· Revolution Medicines, Inc.· Forrás
Contact: Revolution Medicines, Inc.
Fut, nem toboroz
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
NCT05611931· 3. fázis· Karyopharm Therapeutics Inc· Forrás
Toboroz
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
NCT05482893· 1/2. fázis· Phanes Therapeutics· Forrás
Contact: Phanes Therapeutics
Fut, nem toboroz
A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer
NCT05609370· 1/2. fázis· BeiGene· Forrás
Toboroz
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
NCT05480644· Duke University· Forrás
Contact: Kaitlin Bailey, RN
Fut, nem toboroz
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
NCT04971499· 1/2. fázis· April Salama, M.D.· Forrás
Fut, nem toboroz
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT05309655· Duke University· Forrás
Fut, nem toboroz
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
NCT05335993· 2. fázis· CanariaBio Inc.· Forrás
Toboroz
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
NCT04831580· GOG Foundation· Forrás
Contact: Taylor Hayes
Toboroz
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
NCT05098132· 1/2. fázis· Synthekine· Forrás
Toboroz
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
NCT05143996· 1/2. fázis· Cullinan Therapeutics Inc.· Forrás
Contact: Samuel Dell
Toboroz
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
NCT04729114· 1. fázis· Astellas Pharma Global Development, Inc.· Forrás
Contact: Astellas Pharma Global Development, Inc.
Fut, nem toboroz
Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)
NCT04703192· 2. fázis· Daiichi Sankyo· Forrás
Toboroz
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
NCT04775485· 2. fázis· Day One Biopharmaceuticals, Inc.· Forrás
Contact: Day One Biopharmaceuticals, Inc.
Toboroz
Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients
NCT04933435· Duke University· Forrás
Contact: Heather Franklin
Meghívásos bevonás
Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19
NCT04357574· Duke University· Forrás
Fut, nem toboroz
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
NCT03485209· 2. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás
Fut, nem toboroz
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
NCT03767348· 2. fázis· Replimune, Inc.· Forrás